Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28801345.
- Also identified by DOI 10.1136/annrheumdis-2017-211300 and PMC identifier 6724216.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The pathogenetic mechanisms by which <i>HLA-DRB1</i> alleles are associated with anticitrullinated peptide antibody (ACPA)-positive rheumatoid arthritis (RA) are incompletely understood. RA high-risk <i>HLA-DRB1</i> alleles are known to share a common motif, the 'shared susceptibility epitope (SE)'. Here, the electropositive P4 pocket of HLA-DRB1 accommodates self-peptide residues containing citrulline but not arginine. HLA-DRB1 His/Phe13β stratifies with ACPA-positive RA, while His13βSer polymorphisms stratify with ACPA-negative RA and RA protection. Indigenous North American (INA) populations have high risk of early-onset ACPA-positive RA, whereby HLA-DRB1*04:04 and HLA-DRB1*14:02 are implicated as risk factors for RA in INA. However, HLA-DRB1*14:02 has a His13βSer polymorphism. Therefore, we aimed to verify this association and determine its molecular mechanism. HLA genotype was compared in 344 INA patients with RA and 352 controls. Structures of HLA-DRB1*1402-class II loaded with vimentin-64Arg<sub>59-71</sub>, vimentin-64Cit<sub>59-71</sub> and fibrinogen β-74Cit<sub>69-81</sub> were solved using X-ray crystallography. Vimentin-64Cit<sub>59-71</sub>-specific and vimentin<sub>59-71</sub>-specific CD4+ T cells were characterised by flow cytometry using peptide-histocompatibility leukocyte antigen (pHLA) tetramers. After sorting of antigen-specific T cells, TCRα and β-chains were analysed using multiplex, nested PCR and sequencing. ACPA<sup>+</sup> RA in INA was independently associated with <i>HLA-DRB1*14:02</i>. Consequent to the His13βSer polymorphism and altered P4 pocket of HLA-DRB1*14:02, both citrulline and arginine were accommodated in opposite orientations. Oligoclonal autoreactive CD4+ effector T cells reactive with both citrulline and arginine forms of vimentin<sub>59-71</sub> were observed in patients with HLA-DRB1*14:02<sup>+</sup> RA and at-risk ACPA<sup>-</sup> first-degree relatives. HLA-DRB1*14:02-vimentin<sub>59-71</sub>-specific and HLA-DRB1*14:02-vimentin-64Cit<sub>59-71</sub>-specific CD4+ memory T cells were phenotypically distinct populations. HLA-DRB1*14:02 broadens the capacity for citrullinated and native self-peptide presentation and T cell expansion, increasing risk of ACPA+ RA.
Medical subject headings
- Alaska Natives
- Arthritis, Rheumatoid
- Genetic Predisposition to Disease
- HLA-DRB1 Chains
- Indians, North American